Page last updated: 2024-08-23

4-methoxyamphetamine and Autosomal Dominant Myotubular Myopathy

4-methoxyamphetamine has been researched along with Autosomal Dominant Myotubular Myopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Philippidis, A1

Other Studies

1 other study(ies) available for 4-methoxyamphetamine and Autosomal Dominant Myotubular Myopathy

ArticleYear
After Third Death, Audentes' AT132 Remains on Clinical Hold.
    Human gene therapy, 2020, Volume: 31, Issue:17-18

    Topics: Clinical Trials as Topic; Death; Dependovirus; Genetic Therapy; Genetic Vectors; Humans; Myopathies, Structural, Congenital; Protein Tyrosine Phosphatases, Non-Receptor; United States; United States Food and Drug Administration

2020